Ron van Schaik • BioTech Pharma Summit

20171222_10Gold Ron van Schaik Flickr

Ron SCHAIK | Cited by 18,852 | of Erasmus MC, Rotterdam (Erasmus MC) | Read 541 publications | Contact Ron SCHAIK

Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (3) YouTube

Andrews, Louise ; Hesselink, Dennis; van Schaik, Ron et al. / A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.In: British Journal of Clinical Pharmacology. 2019 ; Vol. 85, No. 3. pp. 601-615.

Interview Ron van Schaik

Awesome Books: your haven for affordable literary gems. Quality reads, unbeatable prices. Our extensive selection caters to all readers. Discover your next favourite book with us.

Ron SCHAIK Professor Erasmus MC, Rotterdam Erasmus MC Department of Clinical Chemistry (AKC)

Prof. Dr. Ron van Schaik studied Chemistry at Utrecht University, with specialisations in Biochemistry, Molecular Biology and Clinical Chemistry. He did his PhD on Molecular cloning and Immunological localization of PLA2 at the Dept. Biochemistry of the Center of Biomembranes and Lipid Research (CBML) at Utrecht University,. A 4 year post-doc at the Dept. Endocrinology, Erasmus MC Rotterdam on.

Interview Prof. Ron H. van Schaik YouTube

Simple Summary Although the introduction of programmed cell death 1 (PD-1) immune checkpoint inhibitors (ICIs) has significantly improved the overall survival (OS) in patients with metastatic.

Forward Thinking An Interview with Ron Van Schaik PMF Features

Ron H.N. van Schaik Full Professor Pharmacogenetics / Head Dept Clinical Chemistry / Past-President European Society Pharmacogenomics & Personalised Therapy (ESPT) 10mo

Ron van Schaik Owner CGA Web Design LinkedIn

Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study. ML Becker, LE Visser, RHN van Schaik, A Hofman, AG Uitterlinden,. Diabetes 58 (3), 745-749. , 2009. 313.

Ronald van Schaik Werf&

Dive into the research topics where Ron van Schaik is active. These topic labels come from the works of this person. Together they form a unique fingerprint. 1 Similar Profiles; Circulating Tumor DNA Medicine & Life Sciences 100%. Cytochrome P-450 CYP2D6 Medicine & Life Sciences 87%.

Nieuwe inzichten helpen patiënt in strijd tegen depressie Siemens Healthineers Nederland

prof. dr. Ron van Schaik Full professor, Erasmus MC, Clinical Chemistry https://orcid.org/0000-0003-1864-2151 Overview Fingerprint Network Research output (402) Similar Profiles (1) Supervised Work (5) If you made any changes in Pure these will be visible here soon. Fingerprint Dive into the research topics where Ron van Schaik is active.

Prof. Dr. Ron H.N. van Schaik Laboratoriumspecialist Erasmus MC

Prof. Dr. Ron van Schaik, PhD is a registered European specialist Laboratory medicine (2003) and a Full Professor of Pharmacogenetics (2013). He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, The Netherlands.

Faculty of Pharmaceutical Sciences Ron van Schaik, PhD Michael Smith Laboratories

Ron H.N. van Schaik's Post Ron H.N. van Schaik Full Professor Pharmacogenetics / Head Dept Clinical Chemistry / Past-President European Society Pharmacogenomics & Personalised Therapy (ESPT)

Interview Ron van Schaik

Prof. Dr. Ron van Schaik is hoogleraar Farmacogenetica, en leidt het Internationaal Expertise-laboratorium Farmacogenetica van de Afd. Klinische Chemie. Focus is implementatie van farmacogenetica. Wetenschappelijk onderzoek richt zich op de Oncologie (PGx en ctDNA analyses), Psychiatrie, Transplantatie en de Pijnbestrijding (opioiden.

20181103_19Wintersun Ron van Schaik Flickr

Prof van Schaik has given over 200 invited lectures and participates on multiple national and international advisory committees on pharmacogenetics In 2001, he received the Ortho Clinical Diagnostics Award for Outstanding Research, in 2009 the AACC Outstanding Speaker Award, and in 2010 the AACC/Mol Pathology Award for Outstanding Scientific Research.

Interview Ronald van Schaik (Kaliber) op The Social Conference 2017 YouTube

Prof. Dr. Ron van Schaik (PhD, FACB) is a registered European Specialist Laboratory Medicine and a Full Professor of Pharmacogenetics. He is working at the Dept. Clinical Chemistry at the Erasmus University Medical Center Rotterdam, and is Director of the International (IFCC) Expert-center for Pharmacogenetics.

Ron van Schaik • BioTech Pharma Summit

Ron van Schaik Cytochrome P450 3A4 (CYP3A4) is the most important drug metabolizing enzyme in the liver, responsible for the oxidative metabolism of ∼50% of clinically prescribed drugs.

Ron H van Schaik, Professor, Erasmus University, Rotterdam, the Netherlands (5) YouTube

Contact External Profile About Introduction Publications Other positions Profile of R.H.N. van Schaik, PhD, Erasmus MC, Rotterdam, Professor Pharmacogenetics.